1. Home
  2. UNH vs AZN Comparison

UNH vs AZN Comparison

Compare UNH & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UnitedHealth Group

UNH

UnitedHealth Group

HOLD

Current Price

$368.09

Market Cap

333.1B

Sector

Health Care

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$184.18

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNH
AZN
Founded
1977
1992
Country
United States
United Kingdom
Employees
N/A
96100
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.1B
316.4B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
UNH
AZN
Price
$368.09
$184.18
Analyst Decision
Buy
Strong Buy
Analyst Count
26
1
Target Price
$384.50
N/A
AVG Volume (30 Days)
7.5M
1.9M
Earning Date
04-21-2026
04-29-2026
Dividend Yield
2.38%
1.73%
EPS Growth
N/A
N/A
EPS
6.90
N/A
Revenue
$447,567,000,000.00
N/A
Revenue This Year
N/A
$10.34
Revenue Next Year
$3.64
$6.43
P/E Ratio
$27.46
$31.91
Revenue Growth
11.81
N/A
52 Week Low
$234.60
$66.16
52 Week High
$390.92
$212.71

Technical Indicators

Market Signals
Indicator
UNH
AZN
Relative Strength Index (RSI) 77.42 39.31
Support Level $350.83 $182.39
Resistance Level $378.61 $208.61
Average True Range (ATR) 8.37 2.96
MACD 0.90 -1.70
Stochastic Oscillator 91.66 17.11

Price Performance

Historical Comparison
UNH
AZN

About UNH UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2025. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to affiliates and third parties.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: